Lipid regulating medicines consumption assessment in republic of serbia during the period 2003-2005 year
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Poster
- By: RADONJIC (Medicines and Medical devices Agency, Belgrade, Yugoslavia)
- Co-author(s): Radonjic, Vesela (Medicines and Medical devices Agency, BELGRADE, Serbia and Montenegro)
Solarovic, Tomislav (Medicines and Medical devices Agency, BELGRADE, Serbia and Montenegro)
Lowering the concentration of low density lipoprotein (LDL) cholesterol and raising high density lipoprotein (HDL) cholesterol reduces the progression of coronary atherosclerosis and may induce regresion , it stands to reason on significance of lipid regulating medicines.
The aim of our study was the following consumption of lipid regulating.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.